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Abstract
The intermediate conductance, Ca2+-activated K+ channel (KCa3.1) targets to the basolateral (BL) membrane in polarized
epithelia where it plays a key role in transepithelial ion transport. However, there are no studies defining the anterograde
and retrograde trafficking of KCa3.1 in polarized epithelia. Herein, we utilize Biotin Ligase Acceptor Peptide (BLAP)-tagged
KCa3.1 to address these trafficking steps in polarized epithelia, using MDCK, Caco-2 and FRT cells. We demonstrate that
KCa3.1 is exclusively targeted to the BL membrane in these cells when grown on filter supports. Following endocytosis,
KCa3.1 degradation is prevented by inhibition of lysosomal/proteosomal pathways. Further, the ubiquitylation of KCa3.1 is
increased following endocytosis from the BL membrane and PR-619, a deubiquitylase inhibitor, prevents degradation,
indicating KCa3.1 is targeted for degradation by ubiquitylation. We demonstrate that KCa3.1 is targeted to the BL
membrane in polarized LLC-PK1 cells which lack the m1B subunit of the AP-1 complex, indicating BL targeting of KCa3.1 is
independent of m1B. As Rabs 1, 2, 6 and 8 play roles in ER/Golgi exit and trafficking of proteins to the BL membrane, we
evaluated the role of these Rabs in the trafficking of KCa3.1. In the presence of dominant negative Rab1 or Rab8, KCa3.1 cell
surface expression was significantly reduced, whereas Rabs 2 and 6 had no effect. We also co-immunoprecipitated KCa3.1
with both Rab1 and Rab8. These results suggest these Rabs are necessary for the anterograde trafficking of KCa3.1. Finally,
we determined whether KCa3.1 traffics directly to the BL membrane or through recycling endosomes in MDCK cells. For
these studies, we used either recycling endosome ablation or dominant negative RME-1 constructs and determined that
KCa3.1 is trafficked directly to the BL membrane rather than via recycling endosomes. These results are the first to describe
the anterograde and retrograde trafficking of KCa3.1 in polarized epithelia cells.
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Introduction
In various epithelia, including colonic, airway and salivary
epithelia, agonist-mediated activation of Ca2+-dependent K+
channels (KCa) is known to play a key role in the regulation of
transepithelial ion and water transport. Thus, transepithelial Cl2
secretion requires activation of numerous transporters/channels,
including the Na+/K+-ATPase on the basolateral (BL) membrane
to maintain transmembrane ionic gradients. Also, activation of the
BL membrane Na+-K+-2Cl2 cotransporter allows Cl2 to accu-
mulate above its electrochemical equilibrium. Activation of an
apical membrane Cl2 channel allows Cl2 to move down its
equilibrium potential. Finally, activation of BL membrane K+
channels maintains a membrane potential favorable for the
continuous Cl2 efflux across the apical membrane, while also
recycling K+ taken up by Na+-K+-2Cl2 cotransporter and the
Na+/K+-ATPase. We previously characterized the KCa in colonic
epithelia using both whole-cell [1] and single channel [2] methods
and later confirmed this was KCa3.1 [3] following its molecular
cloning [4,5]. It is now well-recognized that KCa3.1 is a major BL
K+ channel critical for maintenance of the electrochemical driving
force for Ca2+-mediated Cl2 secretion across these epithelia
[6,7,8,9]. Given the critical role of KCa3.1 in maintaining
transepithelial ion and fluid transport, it is not surprising that this
channel has been suggested to play a role in the etiology of various
diseases. Indeed, KCa3.1 has been implicated in Crohn’s disease
[10], ulcerative colitis [11], cystic fibrosis and chronic obstructive
pulmonary disease [12,13] and ADPKD cyst formation [14].
Clearly, a key component dictating the physiological response of
an epithelial cell to an increase in Ca2+ is the number of KCa3.1
channels at the plasma membrane. We [15,16,17] and others [18]
have identified molecular motifs within the N- and C-termini, as
well as the transmembrane domains, that are critical in the
assembly and anterograde trafficking of KCa3.1. Utilizing a Biotin
Ligase Acceptor Peptide (BLAP)-tagged KCa3.1 we demonstrated,
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in human embryonic kidney (HEK293) cells and human
microvascular endothelial (HMEC-1) cells, that KCa3.1 is
endocytosed from the plasma membrane and targeted to the
lysosome via an endosomal complex required for transport
(ESCRT)- and Rab7-dependent pathway [19]. Further, we
demonstrated that KCa3.1 is initially ubiquitylated following
endocytosis and then deubiquitylated by USP8 prior to lysosomal
degradation [20]. Schwab and colleagues [21] have also demon-
strated that KCa3.1 is endogenously expressed in MDCK cells
and that it is endocytosed in a clathrin-dependent manner in non-
polarized, migrating cells.
In contrast to the studies above, there is little information
regarding the anterograde and retrograde trafficking of KCa3.1 in
polarized epithelia. Therefore, the aim of this study was to
investigate the trafficking of KCa3.1 in polarized epithelia. Herein,
we demonstrate that KCa3.1 is expressed solely at the BL
membrane in the model polarized epithelial cell lines, MDCK,
Caco-2, FRT and LLC-PK1, indicating this localization is
independent of the adaptor protein, m1B. In polarized cells,
KCa3.1 is ubiquitylated at the BL membrane and this is increased
following endocytosis after which the channel is targeted for
protosomal and lysosomal degradation. We further demonstrate
that Rab1 and Rab8 are critical for ER/Golgi exit and subsequent
plasma membrane expression of KCa3.1. Finally, we demonstrate
that, following Golgi exit, KCa3.1 does not traffic through either
RME-1- or transferrin receptor (TfnR)-positive recycling endo-
somes on the way to the plasma membrane in polarized epithelia,
suggesting KCa3.1 traffics directly to the plasma membrane.
These results are the first to characterize the anterograde and
retrograde trafficking of KCa3.1 in polarized epithelia cells.
Materials and Methods
Molecular Biology
Our HA-, myc- and biotin ligase acceptor peptide (BLAP)-
tagged KCa3.1 (also referred to as IK1 or SK4) constructs, as well
as the bicistronic plasmid (pBudCE4.1) expressing both BLAP-
KCa3.1 and BirA-KDEL have been previously described
[22,23,24]. BLAP-KCa3.1 was also subcloned in to the pAdlox
(SwaI modified) adenoviral shuttle plasmid using EcoRI and SalI
restriction sites. In order to biotinylate KCa3.1 within the
endoplasmic reticulum before trafficking to the plasma membrane,
we subcloned BLAP-KCa3.1 as well as BirA-KDEL (generously
provided by Dr. Alice Ting, Massachusetts Institute of Technol-
ogy, Cambridge, MA) into the bicistronic adenoviral shuttle
plasmid DUALCCM-CMW-MCS2 (Vector Biolabs; Philadelphia,
PA). In this construct, both cDNAs are located behind unique
CMV promoters. BLAP-KCa3.1 and BirA-KDEL were sequen-
tially subcloned using EcoRI/XhoI and NheI/SalI restriction
sites, respectively. BLAP-KCa3.1 and BirA-KDEL/BLAP-
KCa3.1 replication deficient adenoviruses were generated by the
University of Pittsburgh Vector Core facility and Vector Biolabs,
respectively. The transferrin receptor (TfnR) adenovirus was
generously provided by Dr. Ora Weisz (University of Pittsburgh,
Pittsburgh, PA). Generation of the GFP- and Flag-tagged variants
of Rabs 1, 2, 6 and 8 have been previously described [25,26,27].
Rab 10 was purchased from Addgene (Cambridge, MA). Wild
type (WT) and dominant negative (DN) GFP-tagged receptor-
mediated endocytosis-1 (RME-1) constructs were generously
provided by Dr. Barth Grant (Rutgers University, New Brunswick,
NJ).
Cell Culture
Madin-Darby canine kidney (MDCK) and pig epithelial (LLC-
PK1) cells were cultured in a-MEM medium, human epithelial
colorectal adenocarcinoma (Caco-2) and human embryonic
kidney (HEK293) cells were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen) and Fischer rat thyroid (FRT)
epithelial cells were grown in F12 (Sigma-Aldrich, St. Louis,
MO). All media were supplemented with 10% fetal calf serum,
and 1% penicillin/streptomycin. Both the wild type LLC-PK1 cells
and the LLC-PK1 cell line stably expressing the FLAG-tagged m1B
subunit of the AP1 adaptor complex was generously provided by
Dr. Michael Caplan (Yale University, New Haven, CT) [28]. The
MDCK, Caco-2, HEK293, LLC-PK1 and FRT cell lines were
obtained from the ATCC (Manassas, VA). All cells were grown in
a humidified 5% CO2/95% O2 incubator at 37uC. A stable FRT
cell line was generated by transfecting in the pBudCE4.1 bicistronic
plasmid expressing both BLAP-KCa3.1 and BirA-KDEL using
Lipofectamine 2000 (Invitrogen) following the manufacturer’s
instructions and selecting a stable cell line using zeocin (850
mg/ml) (protocol approved by the University of Otago Institutional
Biological Safety Committee, approval code GMD003298-33).
HEK293 cells were transfected using Lipofectamine 2000
following the manufacturer’s instructions. MDCK, Caco-2,
LLC-PK1 and FRT cells were seeded onto TranswellH permeable
supports (Corning Inc., Corning, NY) and grown to confluence
forming a polarized epithelium (3–4 days post seeding). Polarized
MDCK, Caco-2, LLC-PK1 or FRT cells were transduced with the
BLAP-KCa3.1 or BirA-KDEL/BLAP-KCa3.1 adenoviruses, as
indicated for each experiment. Briefly, well-polarized cells were
washed three times with Ca2+-free PBS followed by addition of
adenovirus to the apical side of the filter. After 1 hr of incubation
at 37uC in a 5% CO2/95% O2 atmosphere, cells were washed
once with PBS and allowed to recover until the next day in normal
growth media. In some experiments, 6 hrs after adenoviral
addition in MDCK cells the cells were further transfected with
WT or DN RME-1 or appropriate Rab construct using
Lipofectamine 2000, following the manufacturer’s instructions.
Biotinylation of KCa3.1 using recombinant biotin ligase
BLAP-tagged KCa3.1 was either biotinylated using recombi-
nant biotin ligase (BirA), as described [22] or by co-expression with
BirA-KDEL [23]. Plasma membrane BLAP-KCa3.1 was then
labeled with streptavidin-Alexa555 (0.01 mg/ml, Invitrogen) for
15 min at 4uC. The cells were extensively washed to remove
unbound streptavidin and incubated for various periods of time at
37uC as indicated or immediately fixed and permeabilized with
2% paraformaldehyde plus 0.1% Triton X-100 [22]. The apical
plasma membrane was labeled with WGA-Alexa488 (wheat germ
agglutinin, 5 mg/ml), (Invitrogen). Nuclei were labeled with DAPI
(Sigma-Aldrich). Cells were imaged by laser-scanning confocal
microscopy (Olympus FluoView 1000 system) using a 636 oil
immersion lens as described [19]. Z-stacks were taken to cover the
entire thickness of the cell in a step size of 0.5 mm.
Antibodies
GFP antibody was obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). Monoclonal a-streptavidin antibody was
obtained from Abcam (Cambridge, MA). Monoclonal Flag, a-
tubulin and b-actin were purchased from Sigma-Aldrich. Anti-
bodies against Myc and HA were obtained from Covance
(Princeton, NJ) and Rab8 antibody was purchased from BD
Transduction laboratories (San Jose, CA).
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Immunoprecipitations and immunoblots
Our immunoprecipitation (IP) and immunoblot (IB) protocols
have been described [15,16]. Briefly, cells were lysed and
equivalent amounts of total protein were pre-cleared with protein
G-agarose beads (Invitrogen) followed by incubation with the
indicated antibody. Normal IgG was used as negative control.
Immune complexes were precipitated with protein G-agarose
beads, washed extensively, and resuspended in Laemmli sample
buffer. Proteins were resolved by SDS-PAGE and transferred to
nitrocellulose for IB analysis. To eliminate interference by the
heavy and light chains of the immunoprecipitating antibody in the
IP, mouse or rabbit IgG Trueblot ULTRA (eBioscience, San
Diego, CA) were used as a secondary antibody for the detection of
immunoprecipitated proteins in the IB.
Determination of degradation rate for plasma membrane
of KCa3.1
The degradation rate for endocytosed membrane KCa3.1 was
determined as described [22]. Briefly, KCa3.1 in polarized
MDCK, Caco-2 or FRT cells was specifically biotinylated using
BirA and labeled with non-conjugated streptavidin after which the
cells were incubated for various periods of time at 37uC, as
indicated. In some experiments, the lysosomal protease inhibitors
leupeptin (100 mM) and pepstatin (1 mg/ml; Leu/Pep) (Sigma-
Aldrich), the proteasome inhibitor lactacystin (10 mM, Lacta) or a
general deubiquitylase (DUB) inhibitor PR-619 (50 mM) (Life-
Sensors Inc., Malvern, PA) were added to both apical and BL
membranes prior to the 37uC incubation step. The cells were then
lysed and equivalent amounts of total protein were separated by
SDS-PAGE, followed by IB for streptavidin. Bands were
quantified by densitometry using ImageJ software (NIH; http://
rsb.info.nih.gov/ij/). The obtained band intensities for the various
time points were normalized relative to the intensity at time 0
(T= 0) and are reported. The blots were also probed for a-tubulin
and b-actin as a protein-loading control.
Pulldown of ubiquitylated KCa3.1 using TUBEs
To determine the ubiquitylation state of KCa3.1 at the plasma
membrane, and following endocytosis, we used GST-tagged
tandem-repeat ubiquitin-binding entities (TUBEs) (LifeSensors
Inc.), as described [20]. Caco-2 cells were enzymatically
biotinylated and streptavidin labeled at the plasma membrane
after which the cells were lysed in the presence of GST-TUBEs
(200 mg/ml) or returned to 37uC for various periods of time to
allow endocytosis to occur, and then lysed in the presence of
TUBEs. The TUBEs were subsequently pulled down on
glutathione agarose beads followed by SDS-PAGE. The resulting
IB was probed with a-streptavidin Ab. In this way, only the
streptavidin-tagged KCa3.1, which was ubiquitylated and hence
bound to TUBEs, was detected [20].
Recycling endosome ablation assay
MDCK cells were transduced with TfnR and BirA-KDEL/
BLAP-KCa3.1 adenoviruses. After 24 hrs, recycling endosome
ablation was carried out based on the methods of Ang et al. [29].
MDCK cells were incubated with 0.010 mg/ml Tfn-HRP and
Tfn-Alexa488 in serum starved media for 45 min at 37uC, washed
twice in serum-free aMEM media, and incubated for 20 min at
37uC. Cells were then washed twice on ice-cold PBS. Surface-
bound Tfn-HRP and Tfn-alexa488 were removed by two 5 min
washes in 0.15 M NaCl plus 20 mM citric acid, pH 5.0. After
washes with ice-cold PBS, the cells were incubated in PBS
containing 0.1 mg/ml diaminobenzidine (DAB; Sigma-Aldrich) in
the absence (control) or presence (ablation) of H2O2 (0.025%) for
1 hr on ice in the dark. The Tfn-HRP reacts with DAB and H2O2
forming an insoluble precipitate that prevents the fusion of post-
Golgi vesicles with the recycling endosome. The ablation reaction
was stopped by washing cells twice in PBS with 1% BSA.
Following recycling endosome ablation, neutravidin biotin binding
protein (600 mg/ml) (Thermo Scientific, Rockford, IL) was added
to the control and ablated cells for 2 hrs at 4uC such that all
plasma membrane localized BLAP-KCa3.1 channels would be
bound and ‘‘blocked’’ from binding to subsequently added
streptavidin. The cells were then incubated in media with
cyclohexamide (400 mg/ml, Sigma-Aldrich) for 90 min at 37uC
to allow ER/Golgi-resident KCa3.1 channels to potentially traffic
to the plasma membrane. To determine whether ER/Golgi-
resident channels had trafficked to the plasma membrane
following recycling endosome ablation we labeled with streptavi-
din-Alexa555 (0.01 mg/ml, Invitrogen) for 15 min at 4uC.
KCa3.1 trafficking from Golgi to the plasma membrane
MDCK cells were transduced with BirA-KDEL/BLAP-KCa3.1
adenovirus and subsequently transfected with GFP-tagged WT or
DN RME-1. Plasma membrane localized and biotinylated BLAP-
KCa3.1 was ‘‘blocked’’ with neutravidin (600 mg/ml), as above. In
order to allow accumulation of channels in the Golgi, cells were
incubated for 2 hrs at 19uC in the continued presence of
neutravidin. Cells were then washed twice on ice-cold PBS, warm
media was added and the cells were incubated for 30 min or 2 hrs
at 37uC to allow channels to traffic to the plasma membrane.
Finally, the newly resident plasma membrane channels were
labeled with streptavidin-Alexa555, for IF localization studies or
with non-conjugated streptavidin followed by IB with a-strepta-
vidin antibody to quantify the rate of plasma membrane KCa3.1
appearance. Similarly, HEK293 cells were transfected with BirA-
KDEL/BLAP-KCa3.1 and each Rab construct followed by
neutravidin ‘‘block’’, incubation at 19uC to allow KCa3.1 Golgi
accumulation and subsequent incubation at 37uC for the indicated
periods of time to allow trafficking of KCa3.1 from the ER/Golgi
to the plasma membrane. Plasma membrane localized KCa3.1
was then labeled with non-conjugated streptavidin, followed by IB
with a-streptavidin antibody to quantify plasma membrane
appearance.
Statistical analysis
All data are presented as means 6 SEM, where n indicates the
number of experiments. Statistical analysis was performed using a
Student’s t-test. To compare the normalized values of the IB band
intensities, statistical analysis was performed using the non-
parametric Kruskal-Wallis test. The traffic from ER/Golgi to
plasma membrane was analyzed using a two-way Anova test
followed by Bonferroni post-test comparing WT and DN at each
time point. A value of p,0.05 is considered statistically significant
and is reported.
Results
Expression and localization of KCa3.1 in polarized
epithelial cells
To determine the plasma membrane localization of KCa3.1 in
polarized epithelial cells, we transduced MDCK, Caco-2 and FRT
cells grown on Transwell filters with BLAP-KCa3.1 adenovirus.
The following day, KCa3.1 was labeled specifically at the plasma
membrane using recombinant BirA followed by incubation with
streptavidin-Alexa555. The apical plasma membrane was
co-labeled with WGA–Alexa488. As shown in Fig. 1A,
Trafficking of KCa3.1 in Polarized Epithelia
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BLAP-KCa3.1 was localized exclusively to the basolateral (BL)
membrane of each of these polarized epithelial cells. These results
were confirmed using TranswellH-grown cells, which were
independently labeled at either the apical (AP) or BL membrane
with streptavidin followed by IB using an a-streptavidin antibody.
As is apparent, KCa3.1 is highly expressed at the BL membrane
with negligible expression associated with the apical membrane
(Fig. 1A). To determine the degradation time of KCa3.1 at the BL
membrane we labeled channels and allowed internalization at
37uC for the indicated periods of time followed by IB, as above. As
shown in Figs. 1B and C, KCa3.1 was degraded with a similar
time-course in MDCK and FRT cells, whereas in Caco-2 cells the
degradation rate was slowed.
Basolateral membrane KCa3.1 is targeted to the
lysosome and proteasome for degradation
To determine whether lysosomes are implicated in the
degradation of BL membrane KCa3.1 we utilized Caco-2 and
FRT cells grown on TranswellH filters under normal conditions
and following inhibition of lysosomal proteases with leupeptin and
pepstatin (Leu/Pep). BLAP-KCa3.1 was biotinylated and labeled
with streptavidin, as above and incubated at 37uC for the times
indicated followed by IB to determine the amount of KCa3.1
remaining. As shown in Fig. 2, in Caco-2 cells 2863% of KCa3.1
remained after 24 hrs and this was increased to 7366% in the
presence of Leu/Pep (n= 4; P,0.05). Also, in FRT cells we
observed a similar effect of Leu/Pep at 5 hrs, i.e., in control cells
2961% of KCa3.1 remained and this was increased to 8164%
Figure 1. Localization and degradation of KCa3.1 in polarized epithelia cells. A. BLAP-KCa3.1 was transduced into MDCK, Caco-2 or FRT
cells grown to confluence on TranswellH filters. Basolateral (BL) and Apical (AP) plasma membrane KCa3.1 channels were specifically biotinylated
using recombinant BirA and labeled with either streptavidin-Alexa555 (red) for IF localization or unconjugated streptavidin for IB. Apical membrane
was co-labeled with wheat germ agglutinin (WGA)-Alexa488 (green) and nuclei were labeled with DAPI (blue) for IF localization. The top panels show
a single confocal section through the mid-plane of the cells and the bottom panels show a z-stack. For the IB experiments, BL and AP membranes
were independently labeled on separate Transwell filters. 30 mg of protein was loaded per lane. Data are representative of 3 separate experiments.
KCa3.1 was localized exclusively to the BL membrane as assessed by both IF and IB. B. KCa3.1 was biotinylated at the BL membrane as above in MDCK
and Caco-2 cells or biotinylated at the level of the ER in FRT cells stably expressing BirA-KDEl/KCa3.1-BLAP and its degradation evaluated over time.
Note the different time points used for each cell line. Tubulin was used as a loading control. C. Quantification of the blots shown in B for at least 3
separate experiments. *P,0.05 with respect to T = 0.
doi:10.1371/journal.pone.0092013.g001
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(n = 6, P,0.05) in the presence of Leu/Pep (data not shown),
indicative of lysosomal degradation following endocytosis.
We also determined whether the proteasome inhibitor,
lactacystin would alter the degradative fate of BL KCa3.1
expressed in polarized epithelia. As shown in Fig. 2, lactacystin
abrogated KCa3.1 degradation such that 6762% of KCa3.1
remained in Caco-2 cells after 24 hrs; significantly more than in
control conditions (n = 4; P,0.05), suggesting a role for the
proteasome in the degradation of BL KCa3.1.
KCa3.1 is ubiquitylated at the plasma membrane and
following endocytosis
To determine whether KCa3.1 is ubiquitylated in polarized
epithelia, Caco-2 cells were grown on TranswellH supports and
KCa3.1 expressed and labeled, as above. As shown in Fig. 3A, at
T= 0, KCa3.1 is localized to the BL membrane and after 8 hrs at
37uC, KCa3.1 has been endocytosed. To evaluate the ubiquityla-
tion of KCa3.1, cells were lysed in the presence of GST-tagged
TUBEs (see Methods) [20]. At T= 0, we observed a small amount
of ubiquitylated KCa3.1 (Fig. 3B, lane 1) and this was significantly
increased following endocytosis for 8 or 12 hrs (8 hrs: 14364%
and 12 hrs: 13961%; n= 3, P,0.05, Fig. 3B, lane 2 and 3),
despite the decreased total expression of KCa3.1 due to
degradation. These results indicate that KCa3.1 is ubiquitylated
at the BL membrane of polarized epithelia and this is increased
following endocytosis.
Deubiquitinating enzymes (DUBs) are proteases that remodel or
cleave ubiquitin from target proteins before they undergo
proteasome-and/or lysosome-degradation [30,31]. We deter-
mined whether DUBs play a role in KCa3.1 degradation in
polarized Caco-2 cells, transduced with BLAP-KCa3.1 and grown
on TranswellH supports, as above. The cells were incubated at
37uC for 24 hrs in the presence or absence of the general DUB
inhibitor, PR-619 after which the expression of KCa3.1-BLAP was
evaluated by IB. As shown in Fig. 3C and D, after 24 hrs KCa3.1
was extensively degraded, averaging 2461% of that observed at
T= 0 (n= 3; P,0.05), similar to our results above. In PR-619
treated cells, channel degradation was significantly inhibited with
8761% of KCa3.1 still remaining after 24 hrs (n = 3; P,0.05).
The lysosomal protease inhibitors Leu/Pep were used as a positive
control in these experiments and prevented degradation of
KCa3.1, similar to our results above with 6862.6% of KCa3.1
remaining (P,0.05). These results suggest that the deubiquityla-
tion of KCa3.1 by DUBs is required for proper degradation of the
channel in polarized epithelia.
Trafficking of KCa3.1 from the ER/Golgi to the plasma
membrane requires Rab1 and Rab8
Rabs 1, 2 and 6 have been shown to be involved in the
trafficking of proteins from the ER to Golgi, whereas Rabs 8 and
10 are known to be involved in the trafficking of protein from the
Golgi to the plasma membrane [26,27,32,33]. We initially
determined whether these Rabs are involved in the trafficking of
KCa3.1 to the plasma membrane in HEK293 cells. For these
studies, we co-transfected BirA-KDEL/BLAP-KCa3.1 with either
WT, DA or DN forms of each of these Rabs such that BLAP-
KCa3.1 would be biotinylated in the ER. Plasma membrane
BLAP-KCa3.1 was then detected by streptavidin labeling and IB,
as above. We evaluated total KCa3.1 expression by co-transfecting
a myc-tagged KCa3.1 with the relevant Rabs and blotted for myc.
As shown in Figs. 4A and B, while WT or DA forms of Rab1
(Q70L) and Rab 8 (Q67L) did not affect plasma membrane
expression of KCa3.1, dominant negative Rab8 (T22N: 37610%,
n=3; P,0.05) and Rab1 (N124I: 4864%; S25N: 4468%; n= 3;
P,0.05) significantly decreased KCa3.1 plasma membrane
expression. In contrast, we did not observe any effect of Rabs 2
or 6 on plasma membrane expression of KCa3.1 (Fig. 4B).
Similarly, we observed no effect of Rab 10 on plasma membrane
expression of KCa3.1 (data not shown). We also determined
whether the effects of the Rabs observed were specific for KCa3.1
or whether the plasma membrane expression of another family
member, KCa2.3, would be similarly affected. As shown in
Fig. 4D, Rabs 1, 2, 6 or 8 had no effect on plasma membrane
expression of KCa2.3.
We also carried out co-IP experiments to determine whether
KCa3.1 is associated with Rab1 WT/DN or Rab8 WT/DN.
Thus, we co-transfected HA-tagged KCa3.1 with either Flag-
tagged Rab1 or GFP-tagged Rab8 in to HEK293 cells and
immunoprecipitated with a-HA antibody followed by IB for the
appropriate heterologously expressed Rab. As shown in Figs. 5A
and B, KCa3.1 co-immunoprecipitated predominantly with the
DN forms of Rab1 and Rab8. Additionally, in our Rab8
experiments we were able to directly assess interactions between
KCa3.1 and endogenous Rab8 by blotting using an aRab8 Ab. As
shown in Fig. 5B (lower panel), we were able to co-IP endogenous
Rab8 with KCa3.1 in the presence of heterologously expressed
Figure 2. BL localized KCa3.1 is degraded in the lysosome.
BLAP-KCa3.1 was transduced in Caco-2 cells grown to confluence on
TranswellH filters and BL plasma membrane channels specifically
biotinylated and labeled with streptavidin. Cells were treated with
leupeptin (100 mM) and pepstatin (1 mg/ml) (Leu/Pep) or lactacystin
(10 mM, Lacta) and degradation of KCa3.1 determined. Both Leu/Pep
and Lacta inhibited degradation of KCa3.1. 30 mg of protein was loaded
per lane. Averages from 3 experiments are plotted below; *P,0.05 with
respect to T = 0, # P, 0.05 with respect to T = 24 hrs in Caco-2 cells.
doi:10.1371/journal.pone.0092013.g002
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WT and DN Rab8. Indeed, we observed similar levels of
endogenous Rab8 in both conditions, indicating that some Rab8
continues to associate with KCa3.1 and promote forward
trafficking of the channel in the presence of DN Rab8.
If the expression of a DN Rab is slowing the exit of KCa3.1
from the ER/Golgi this should be apparent as a decreased rate of
trafficking to the plasma membrane. Our method for defining this
step is shown by IF in Fig. 6A. For these studies, we expressed
BirA-KDEL/BLAP-KCa3.1 in HEK293 cells. Expression of
BLAP-KCa3.1 at the plasma membrane is confirmed by
streptavidin-Alexa488 labeling (T= 0 at 4uC). Immediately
labeling with streptavidin-Alexa555 results in no signal (T= 0 at
4uC; Strep-555), confirming that the biotin sites on KCa3.1 are
saturated or ‘‘blocked’’ by streptavidin-Alexa488 binding. The
cells are then incubated at 19uC for 2 hrs to accumulate BLAP-
KCa3.1 in the ER/Golgi (T= 2 hrs at 19uC). As is apparent, some
of the streptavidin-Alexa488 channel has been endocytosed during
this 19uC incubation step, however, no additional channel has
trafficked to the plasma membrane as assessed by the lack of
streptavidin-Alexa555 labeling. Following incubation of the cells at
37uC for 80 min, we observed small green puncta inside the cell
consistent with endocytosis of plasma membrane KCa3.1. In
addition, new channels have trafficked to the plasma membrane
from the ER/Golgi such that they can be ‘‘captured’’ as is
apparent by our ability to label these newly arrived channels with
streptavidin-Alexa555. To quantify this rate, we utilized neutra-
vidin to ‘‘block’’ existing BLAP-KCa3.1 channels at the plasma
membrane and ‘‘captured’’ newly arrived channels with strepta-
vidin followed by IB, as above. The amount of channel ‘‘captured’’
at any time point was then compared to the amount of channel
present at T= 0, which represents steady-state expression levels.
Any signal left following ‘‘block’’ was subtracted from all
subsequent time points as this represented the amount of channel
that could not be bound by neutravidin. As shown in Fig. 6B,
KCa3.1 rapidly exits the ER/Golgi and begins to appear at the
plasma membrane within 10 min and the level of channel
expression continues to increase over time. In the presence of
WT Rab1 or Rab8 after 2 hrs at 37uC expression levels of KCa3.l
at the plasma membrane had returned to 5467% and 4665% of
those seen at T= 0, respectively. In contrast, in the presence of DN
Rab1 and Rab8 this was only 2867 (n = 3; P,0.05) and 2764%
(n= 3; P,0.05), respectively, indicating that expression of DN
Rab1 and Rab8 decreases the rate of KCa3.1 trafficking from the
ER/Golgi to the plasma membrane.
Figure 3. KCa3.1 is ubiquitylated following endocytosis in polarized Caco-2 cells. A. IF localization of KCa3.1 (red) in confluent Caco-2 cells
on TranswellH filters following labeling as in Fig. 1 at T = 0 and following 8 hrs at 37uC. After 8 hrs, KCa3.1 is endocytosed. Nuclei are labeled with
DAPI (blue). B. Ubiquitylated KCa3.1 was evaluated by TUBEs pulldown at T = 0 when KCa3.1 is localized to the BL membrane and following
endocytosis for 8 and 12 hrs (see Methods). An increase in ubiquitylated KCa3.1 is apparent at 8 and 12 hrs despite the channel being degraded
[strep(KCa3.1) blot]. Actin was used as a loading control. C. Inhibition of deubiquitylases by PR-619 (50 mM) prevents degradation of KCa3.1. Leu/Pep
was used as a control for these experiments. 30 mg of protein was loaded per lane. Actin was used as a loading control. D. Quantification of the blots
shown in C for at least 3 separate experiments; *P,0.05 with respect to T = 0, # P,0.05 with respect to T = 24 hrs.
doi:10.1371/journal.pone.0092013.g003
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We further determined whether Rabs 1 and 8 are involved in
the trafficking of KCa3.1 to the plasma membrane in polarized
MDCK and FRT cells. Initially, we carried out IF studies by
transducing BirA-KDEL/BLAP-KCa3.1 and transfecting either
WT or DN Flag-Rab1 or GFP-Rab8. BLAP-KCa3.1 was
labeled at the plasma membrane with streptavidin-Alexa555 and
Figure 4. Plasma membrane localized KCa3.1 is decreased by DN Rab1 and Rab8, but not by Rab2 or Rab6. HEK293 cells were co-
transfected with BLAP-KCa3.1 and either WT, DA or DN Rabs 1, 2, 6 or 8 and plasma membrane localized KCa3.1 evaluated by specific biotinylation,
streptavidin labeling and IB (see Methods). As shown in A and C, DN Rab8 (T22N) and two different DN Rab1s (N124I, S25N) decreased expression of
plasma membrane KCa3.1. In contrast, DN Rab2 and Rab6 had no effect on membrane expression of KCa3.1 (B and C). 30 mg of protein was loaded
per lane. The bar graphs in C are averages of 3 experiments; *P,0.05 with respect to WT Rabs. D. HEK293 cells were co-transfected with BLAP-KCa2.3
and either WT, DA or DN Rabs 1, 2, 6 or 8 and membrane localized KCa2.3 evaluated as above. None of these Rabs had any effect on membrane
expression of KCa2.3 (n = 3).
doi:10.1371/journal.pone.0092013.g004
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Flag-Rab1 was labeled with a-Flag Ab following fixation/
permeabilization; GFP-Rab8 was directly visualized. As shown
in Fig. 7A, expression of either DN Rab1 (N124I) or Rab8 (T22N)
resulted in an apparent decrease in plasma membrane expression
of KCa3.1. To confirm this result biochemically, we carried out IB
of plasma membrane BLAP-KCa3.1. As shown in Figs. 7B and C,
both DN Rab1 and Rab8 resulted in a significant decrease in
plasma membrane expression of KCa3.1 in both MDCK and
FRT cells. In 3 experiments, Rab1 N124I decreased plasma
membrane expression to 6063% and 4567% (P,0.05) of that
observed following WT Rab1 expression in MDCK and FRT
cells, respectively (Fig. 7C). Similarly, Rab8 T22N decreased
plasma membrane expression to 5768% and 4764% (P,0.05) of
that observed following WT Rab8 expression in MDCK and FRT
cells, respectively (Fig. 7C). Similar to our HEK293 data, DN
Rab2 had no effect on plasma membrane KCa3.1 expression in
MDCK cells (Fig. 7B).
The AP-1 adaptor protein, m1B is not required for proper
BL sorting of KCa3.1 in polarized epithelia
It has been shown that the m1B subunit of the adaptor protein
complex AP-1 is important in the BL sorting of several proteins in
polarized epithelia [34]. Importantly, while m1B is expressed in
MDCK cells it is not expressed in LLC-PK1 cells resulting in the
mis-targeting of some BL proteins [35]. To determine whether
m1B was required for BL targeting of KCa3.1 we transduced
BLAP-KCa3.1 in to both parental and m1B-Flag corrected LLC-
PK1 cells and evaluated BL vs apical localization by both IF and
IB, as above. As shown in Fig. 8, KCa3.1 was targeted to the BL
membrane in both LLC-PK1-WT and m1B-expressing LLC-PK1
cells based upon both IF (A) and IB (B). Expression of m1B was
confirmed by IB (Fig. 8C). These data indicate that the BL sorting
of KCa3.1 in polarized epithelia is independent of the m1B subunit
of AP-1 complex.
KCa3.1 traffics directly to the basolateral plasma
membrane in polarized epithelia
It has been shown that proteins destined for the BL membrane
can traffic either: 1) from the Golgi to the BL membrane directly
or 2) from the Golgi through recycling endosomes to the BL
membrane [36,37]. To determine whether KCa3.1 traffics via
recycling endosomes we carried out recycling endosome ablation
in MDCK cells [29]. We transduced MDCK cells with both
transferrin receptor (TfnR) and BirA-KDEL/BLAP-KCa3.1
adenoviruses. Initially, both Tfn-HRP and Tfn-Alexa488 were
bound to TfnR and allowed to internalize for 45 min at 37uC,
thereby allowing the TfnR with bound substrate to traffic through
early and recycling endosomes. Subsequently, BLAP-KCa3.1 was
labeled with either streptavidin-Alexa555, to confirm expression of
the channel at the plasma membrane at T= 0, or neutravidin to
‘‘Block’’ plasma membrane resident channels (see also, Fig. 6). As
shown in Fig. 9, at T= 0 Tfn-Alexa488 was located in endosomal
compartments, as is apparent from the green puncta, whereas
KCa3.1 is localized to the plasma membrane. Next, recycling
endosome ablation was carried out by treating the cells with DAB,
in the absence (control) or presence (ablation) of H2O2. As is
apparent in the images labeled ‘‘Block’’, in the absence of DAB the
Tfn-Alexa488 is located in vesicles throughout the cytoplasm,
Figure 5. KCa3.1 immunoprecipitates with Rab1 and Rab8. A. Co-IP of HA-tagged KCa3.1 and either WT or DN Rab1 (Flag) was carried out in
HEK293 cells as described in the Methods. Total cell lysates were subject to IP using either an a-HA Ab (lanes 5, 6) or an a-V5 Ab as IgG control (lanes
3, 4) and subsequently blotted for Rab1 (a-Flag). B. Co-IP of HA-tagged KCa3.1 and either endogenous (bottom panel) or GFP-tagged WT and DN
Rab8 (top panel). Total cell lysates were subject to IP as in A and subsequently IB for either endogenous Rab8 (a-Rab8) or GFP-tagged Rab8 (a-GFP).
Lysates for WT and DN Rab1 or 8 are shown in the first two lanes of each blot (5 mg loaded per lane). These data confirm an association between
KCa3.1 and Rabs1 and 8. Data are representative of 3 experiments.
doi:10.1371/journal.pone.0092013.g005
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Figure 6. DN Rab1 and Rab8 slow ER/Golgi-to-plasma membrane delivery of KCa3.1. A. IF illustration of plasma membrane BLAP-KCa3.1
blocking protocol and subsequent appearance of new BLAP-KCa3.1 to the plasma membrane along the biosynthetic pathway. HEK293 cells were
transfected with BLAP-KCa3.1 and BirA-KDEL in the pBudCE4.1 plasmid such that BLAP-KCa3.1 is specifically biotinylated at the level of the ER (see
Methods). Top row: Plasma membrane BLAP-KCa3.1 was labeled with strepatavidin-Alexa488 (left; green) and subsequently with streptavidin-
Alexa555 (middle; red). As is apparent, strep-488 saturated the biotin binding sites, precluding strep-555 labeling; demonstrating block of existing
plasma membrane localized KCa3.1 channels.Middle row: Following 2 hrs at 19uC to accumulate KCa3.1 in the Golgi, some of the channels initially
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whereas in the presence of DAB the Tfn-Alexa488 is localized
exclusively to perinuclear recycling endosomes, as reported [29].
These results confirm recycling endosome ablation such that TfnR
can no longer exit from these vesicles. Also, BLAP-KCa3.1 could
not be labeled by streptavidin-Alexa555, confirming ‘‘Block’’ by
neutravidin. Finally, the cells were returned to 37uC for 2 hrs in
the presence of cyclohexamide such that KCa3.1 could exit the
Golgi and traffic to the plasma membrane after which these
channels were labeled with streptavidin-Alexa555. As shown
(Block +2 hrs 37uC), KCa3.1 trafficked to the plasma membrane
in both the control and recycling endosome ablated cells,
consistent with KCa3.1 trafficking directly to the plasma
membrane rather than via the TfnR-positive recycling endosomes.
As an alternate strategy to disrupt recycling endosomes we co-
expressed either WT or DN RME-1 (G429R) with BLAP-KCa3.1.
DN RME-1 induces redistribution of recycling endosomes and
inhibits the exit of proteins such that cargo delivered to the DN
RME-1 positive endosomes becomes trapped in this compartment
[38]. Thus, we determined whether expression of G429R-RME-1
would inhibit delivery of KCa3.1 to the plasma membrane
following Golgi exit. MDCK were transduced with BirA-KDEL/
BLAP-KCa3.1 adenovirus and transfected with WT or DN GFP-
tagged RME-1. As shown in Fig. 10A, at T= 0, KCa3.1 was
labeled with strepavidin-Alexa555 at the plasma membrane in the
presence of WT or DN RME-1 and this labeling could be blocked
by neutravidin (Block). Following incubation at 19uC to accumu-
late KCa3.1 in the Golgi, we were unable to detect KCa3.1 in the
plasma membrane (Block+19uC), as above (Figs. 6 and 9). Finally,
the MDCK cells were returned to 37uC for 2 hrs to allow channels
to exit the Golgi and traffic to the plasma membrane after which
the channel was labeled with strepavidin-Alexa555 (Block+19-
uC+2 hrs 37uC). As is apparent, in both WT and DN RME-1-
expressing MDCK cells, KCa3.1 trafficked to the plasma
membrane. We confirmed this result by IB by determining
whether the rate of KCa3.1 appearance at the plasma membrane
was altered by DN RME-1 expression. As shown Figs. 10B and C,
blocking with neutravidin eliminated the signal associated with
plasma membrane KCa3.1. After Golgi release at 37uC for
20 min KCa3.1 is clearly apparent at the plasma membrane and
this expression increases after 2 hrs. Importantly, similar levels of
KCa3.1 were expressed at the plasma membrane in MDCK cells
expressing either WT or G429R RME-1. In 3 experiments, after
2 hrs at 37uC there was no difference in expression of KCa3.1 at
the plasma membrane, being 66611% of control (T= 0) in WT
RME-1 expressing cells and 6266% of control (T= 0) in G429R
RME-1 expressing cells (Fig. 10C). These results further demon-
strate that KCa3.1 traffics directly from the Golgi to the BL
membrane rather than indirectly via recycling endosomes.
Finally, we determined whether TfnR would be trapped in
RME-1-positive endosomes by transducing MDCK cells with
TfnR followed by transfection with either WT or DN GFP-tagged
RME-1. TfnR was bound to Tfn-Alexa546 and allowed to
endocytose for 45 min at 37uC, after which the cells were fixed for
IF localization. As shown in Fig. 10D, in the presence of WT
RME-1, the TfnR is in endosomes throughout the cytoplasm.
However, in the presence of DN RME-1, the TfnR is clustered in
the RME-1-positive compartment. This result confirms that DN
RME-1 is capable of trapping proteins that traffic via recycling
endosomes.
Discussion
It is now clear, based on both electrophysiological and
pharmacological data, that KCa3.1 is expressed in the BL
membrane of numerous epithelia [6,7,8,9]. However, more recent
evidence has demonstrated K+ secretion in both primary cultures
of human bronchial epithelium [12] and proximal colon [39] that
is sensitive to block by apical charybdotoxin and clotrimazole;
indicative of KCa3.1 channels in the apical membrane. Based on
these data, Rajendran and colleagues [40] identified a unique
transcript, KCNN4c, that lacks exon 2 which encodes for the
second transmembrane domain of KCa3.1. These authors
demonstrated that this channel targeted to the apical membrane
when co-assembled with the large conductance, Ca2+-activated K+
channel b-subunit [40]. While these data demonstrate that
KCa3.1 can be targeted to either the apical or BL membrane of
polarized epithelia, depending on the transcript expressed, there is
no information to date demonstrating how this channel is targeted
to the BL membrane or its’ endocytic fate once it is in the BL
membrane. Herein, we have used the BLAP-tagged KCa3.1 to
begin to address these questions. We demonstrate that KCa3.1-
BLAP is highly expressed at the BL membrane with insignificant
expression in the apical membrane of three different polarized
epithelial cell models, MDCK, Caco-2 and FRT (Fig. 1A). Similar
to what we previously reported in HEK293 cells [22], KCa3.1 was
degraded with a half-time of ,3-5 hrs in MDCK and FRT cells.
However, in Caco-2 cells the half-time for degradation was
significantly longer, being ,16 hrs (Fig. 1B). At present it is
unclear why the degradation of KCa3.1 is slowed in Caco-2 cells.
While this may suggest that KCa3.1 degradation is uniquely
regulated in intestinal epithelia, more studies are required to
determine this.
We demonstrate that, following endocytosis from the BL
membrane of polarized epithelia, degradation is blocked by
inhibiting lysosomal proteases (Fig. 2); similar to what we
previously reported in HEK293 cells [19]. While we have
demonstrated a role for p97/Derlin-1 and the proteasome in the
degradation of mis-folded KCa3.1 channels in the ER [17] a role
for the proteasome in the degradation of KCa3.1 following
endocytosis has not been investigated. As shown in Fig. 2,
lactacystin inhibited KCa3.1 degradation, indicative of a role for
the 26 S proteasome in targeting KCa3.1 to the lysosome for
degradation. Numerous studies have shown that the degradation
of membrane resident proteins is also blocked by inhibitors of the
labeled at the plasma membrane (strep-488) have been endocytosed. Labeling with strep-555 demonstrates that no new channels have trafficked to
the plasma membrane during this 19uC incubation, as expected. Bottom row: Further incubation at 37uC for 80 min results in endocytosis of KCa3.1
channels initially labeled with strep-488 at T = 0. Labeling with strep-555 demonstrates that new KCa3.1 channels have appeared at the plasma
membrane, consistent with trafficking out of the Golgi. Nuclei are labeled with DAPI (blue). B. Experiments were carried out as illustrated in A except
that blocking of existing plasma membrane KCa3.1 was carried out using neutravidin. As shown in lane 2 for each blot, neutravidin eliminated greater
than 90% of the labeling attributed to streptavidin binding to plasma membrane BLAP-KCa3.1. Within 10 min incubation at 37uC, KCa3.1 begins to
appear at the plasma membrane following ER/Golgi exit. After 2 hrs, KCa3.1 has recovered ,50% relative to T= 0 in the presence of WT Rab1 and
Rab8, whereas this is decreased to ,27% in the presence of DN Rab1 and Rab8. 30 mg of protein was loaded per lane. The average of 3 experiments
is shown in the bar graphs. The solid bars indicate expression of KCa3.1 in the presence of WT Rab while the open bars show expression of KCa3.1 in
the presence of DN Rab (* P,0.05 with respect to same period of time with WT Rab). ‘‘,’’ indicates a non-specific band. These results indicate that
DN Rab1 and Rab8 slow exit of KCa3.1 from the ER/Golgi resulting in decreased plasma membrane expression as suggested in Fig. 4.
doi:10.1371/journal.pone.0092013.g006
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Figure 7. DN Rab1 and Rab8 decrease plasma membrane expression of KCa3.1 in polarized epithelia. A. BLAP-KCa3.1 and either WT or
DN Flag-Rab1 (N124I) (top row) or GFP-Rab8 (T22N) (bottom row) were transfected into confluent MDCK cells. Plasma membrane KCa3.1 was labeled
with streptavidin-Alexa555 (red) after which the cells were fixed/permeabilized and Rab1 labeled with a-Flag Ab (Rab8 is GFP tagged). Both DN Rab1
(top panels) and Rab8 (bottom panels) result in an apparent decrease in plasma membrane KCa3.1 expression. Nuclei are labeled with DAPI (blue). B.
BLAP-KCa3.1 and either WT or DN Flag-Rab1 (N124I) or GFP-Rab8 (T22N) were transfected into either MDCK (left) or FRT (right) cells and plasma
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proteasome [41,42,43]. In this regard, it has been suggested that
the ubiquitin-proteasome pathway is involved in the endosomal
sorting step of some proteins to the lysosome [44]. More recently,
it was shown that Ecm29 binds the 26 S proteasome and links the
proteasome to various endocytic proteins, including Rab11 and
rabaptin via its N-terminal end and molecular motors via its C-
terminal end [45]. Also, proteasomal inhibition by MG132 for
20 hrs caused redistribution of the endosomal adaptor protein,
APPL1 as well as the early endosomal marker, Rab5 to the
perinuclear region of cells, whereas the early endosomal marker,
EEA1 was unaffected [46]. Thus, the 26 S proteasome may be
directly coupled to KCa3.1-containing endosomes, thereby
influencing its’ degradation.
To date, more than 60 Rabs have been identified and it is
thought that each Rab is related with a particular organelle or
pathway [32,47]. Rab 2 has been shown to be predominantly
localized to the ER/Golgi intermediate compartment (ERGIC)
where it is involved in the retrograde transport from the ERGIC to
the ER [48]. Rab 6 is mainly localized to the Golgi and the trans-
Golgi network (TGN) where it modulates the retrograde transport
between the Golgi cisternae or from the Golgi to the ER [25].
Expression of DN Rab 2 and Rab 6 have been shown to inhibit
the anterograde transport of numerous proteins, including the
cystic fibrosis transmembrane conductance regulator (CFTR) and
G-protein coupled receptors (GPCR) [48,49]. Also, Rab 1 is
localized in the ER and the Golgi where it regulates anterograde
transport from the ER to the Golgi and among the Golgi
compartments [32]. The manipulation of Rab1 function has been
shown to block the ER to cell surface transport of a-adrenergic,
angiotensin II type 1 and human calcium sensing receptors
[50,51,52]. Finally, Rab 8 and Rab 10 have been extensively
investigated in polarized epithelial cells where they have been
shown to play a role in protein trafficking from the Golgi to the BL
membrane [27,33,53]. Herein, we demonstrate that Rab1 and
Rab8 play a crucial role in the anterograde trafficking of KCa3.1
to the BL membrane of polarized MDCK cells (Fig. 7), whereas
Rabs 2, 6 and 10 appear to play no role in KCa3.1 trafficking.
Indeed, we demonstrate that expression of DN Rab1 or Rab 8
slowed the appearance of KCa3.1 to the plasma membrane in
HEK cells (Fig. 6), consistent with their known roles in the forward
trafficking of various proteins [27,50,51]. Interestingly, a closely
related family member, KCa2.3 was unaffected by expression of
DN forms of any of these Rabs (Fig. 4D), indicating a high degree
of specificity amongst these KCa family members. Unfortunately,
chimeras between KCa3.1 and KCa2.3 did not reveal any
apparent domains critical for this Rab-dependent trafficking of
KCa3.1 (C.A. Bertuccio and D.C. Devor, unpublished observa-
tions).
GPCR have been shown to directly interact with members of
the Rab family, including Rab1 and Rab8 which interact with
b2- and a2- adrenergic receptors [27,54]. Herein, we demonstrate
a close association between KCa3.1 and WT or DN Rab1 and
Rab8 by co-IP (Fig. 5). Interestingly, KCa3.1 preferentially
associates with the inactive, GDP-bound form of Rab1 and
membrane KCa3.1 evaluated by IB (see Methods). WT and DN Rab2 were transfected in to MDCK cells together with BLAP-KCa3.1 as a negative
control based on our HEK298 data (Fig. 4). 10 mg of protein was loaded per lane. Tubulin was used as a loading control. Expression of Rab1 and Rab8
were confirmed by IB using a-Flag and a-GFP Ab, respectively. C. Quantification of 3 separate blots demonstrates that DN Rabs1 and 8 decrease
plasma membrane expression of KCa3.1 in both MDCK and FRT cells (*P,0.05 with respect to WT Rabs), whereas DN Rab2 had no effect on
membrane KCa3.1 expression in MDCK cells.
doi:10.1371/journal.pone.0092013.g007
Figure 8. Basolateral targeting of KCa3.1 is independent of the adaptor protein, m1B. A. BLAP-KCa3.1 was transduced in to either WT LLC-
PK1 cells (left panels) or LLC-PK1 cells stably expressing m1B (right panels) grown to confluence on TranswellH filters. The AP and BL membranes were
biotinylated using recombinant BirA and biotinylated proteins labeled with streptavidin-Alexa555 (red). Apical membrane was co-labeled with WGA-
Alexa488 (green). Nuclei were labeled with DAPI (blue). The top panels show a single confocal section through the mid-plane of the cells and the
bottom panels show a z-stack. KCa3.1 was detected exclusively in the BL of both LLC-PK1 clones. B. Either AP or BL membranes of WT LLC-PK1 cells
(left panel) or LLC-PK1 cells stably expressing m1B (right panel) grown to confluence on TranswellH filters were biotinylated using BirA followed by
streptavidin labeling and subsequent IB to determine localization of KCa3.1. KCa3.1 was localized specifically to the BL membrane in both LLC-PK1
clones. Tubulin was used as a loading control. Blots are representative of 3 separate experiments. 20 mg of protein was loaded per lane. C. IB
confirming expression of Flag-tagged m1B in the LLC-PK1-m1B cell line.
doi:10.1371/journal.pone.0092013.g008
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Rab8, similar to what has been described for some GPCR [27,54].
Indeed, it has been suggested that these receptors can interact with
and activate Rab GTPases, thus facilitating their own transport
[27,55], although this is not known for KCa3.1.
Sorting of numerous proteins to the BL domain of polarized
epithelia is the result of an association with the m1 subunit of the
adaptor protein-1 complex (AP-1) [56,57]. The AP-1 complex is
the only clathrin-associated adaptor complex implicated in BL
sorting in polarized epithelia [58]. Importantly, while m1B is
expressed in MDCK and Caco-2 cells it is not expressed in LLC-
PK1 cells. Lack of the m1B subunit in LLC-PK1 cells has been
shown to result in the mistargeting of some BL proteins to the
apical surface and stable expression of m1B restores proper BL
targeting [35]. In addition, Ang et al. demonstrated that Rab8 acts
in conjunction with AP-1B to target proteins to the BL membrane
of polarized epithelia [53]. Since KCa3.1 is endogenously
expressed in MDCK cells [59], is endocytosed in a clathrin-
dependent manner [21] and its plasma membrane expression is
modulated by Rab8 (Figs. 4 and 7), we evaluated whether m1B was
required for BL targeting of KCa3.1 using both LLC-PK1-WT
and m1B-expressing LLC-PK1 cells. As shown in Fig. 8, KCa3.1
was targeted to the BL membrane in both WT and m1B-expressing
LLC-PK1 cells, indicating that the BL sorting of KCa3.1 in
polarized epithelia is independent of the m1B subunit of the AP-1
complex. Similarly, Caplan and colleagues demonstrated that the
sorting of the H+/K+-ATPase and Na+/K+-ATPase were inde-
pendent of m1B expression in polarized epithelia [28,60].
As noted, proteins trafficking to the plasma membrane along the
biosynthetic route, in both polarized and non-polarized cells, can
either traffic directly from the Golgi to the plasma membrane or
they can transit via recycling endosomes [29,32,37,61,62]. To
determine whether KCa3.1 traffics through recycling endosomes
before arriving at the plasma membrane, we monitored KCa3.1
appearance at the plasma membrane using two separate strategies.
First, we carried out recycling endosome ablation using Tfn-HRP
which resulted in the TfnR being trapped in a perinuclear
compartment (Fig. 9) [29]. However, KCa3.1 trafficked to the BL
membrane, indicating this channel does not traffic through TfnR-
positive recycling endosomes. Second, we utilized a DN RME-1
approach to disrupt recycling endosomes. Lin et al. [38] showed
that a mutation in the epsin homology domain (G429R) induced
redistribution of recycling endosomes and inhibits the exit of
proteins from this compartment. We demonstrated that, following
endocytosis, KCa2.3 is targeted to this RME-1-positive compart-
ment, whereas KCa3.1 was not [22]. In Fig. 10, we show that
KCa3.1 is similarly not targeted to recycling endosomes following
Golgi exit along the biosynthetic route. Indeed, we demonstrate
that the rate of KCa3.1 appearance at the plasma membrane is
not altered by DN RME-1 expression (Fig. 10B), suggesting no
alteration in the rate of delivery. Thus, using two separate methods
of disrupting the recycling endosome compartment demonstrates
that KCa3.1 does not traffic through this compartment along the
biosynthetic route.
The regulated trafficking of proteins to the BL membrane is an
important process that controls the amount of protein at the cell
surface and thereby modulates their function. Herein, we
demonstrate that KCa3.1 is targeted to the BL membrane of
polarized epithelia in a Rab1- and Rab8-dependent manner.
However, following Golgi exit the correct BL targeting of KCa3.1
is independent of the AP-1B complex. In addition, we demonstrate
that the trafficking itinerary of the newly synthesized KCa3.1
channels does not involve passage through the recycling endosome
compartment. Finally, following correct insertion in to the BL
membrane, KCa3.1 is endocytosed and targeted for lysosomal
degradation in a process that requires initial ubiquitylation
followed by de-ubiquitylation. Inhibition of this process by
lactacystin indicates that proteasomes are functionally associated
with KCa3.1-containing endosomes.
Figure 9. KCa3.1 does not traffic via transferrin-positive recycling endosomes to the plasma membrane in MDCK cells. MDCK cells
were transduced with Transferrin receptor (TfnR) and BirA-KDEL/BLAP-KCa3.1 after which the TfnR was bound to a mixture of Tfn-Alexa488 (green)
and Tfn-HRP and allowed to endocytose for 40 min at 37uC. Plasma membrane BLAP-KCa3.1 was then labeled with streptavidin-Alexa555 (red). This is
shown in the left panel (T = 0) and confirms that under these conditions we are able to label both TfnR and KCa3.1 in confluent MDCK cells. To
determine whether KCa3.1 traffics to the plasma membrane via TfnR-positive recycling endosomes, we labeled the TfnR as above and blocked
plasma membrane BLAP-KCa3.1 with neutravidin. Subsequently, recycling endosome ablation was carried out by reacting the Tfn-HRP with H2O2 +
DAB (DAB was omitted as a non-ablation control) and ER/Golgi exit allowed to proceed for 2 hrs at 37uC after which KCa3.1 that was newly trafficked
to the plasma membrane was labeled with strep-555 (see Methods and Results sections for additional details). As shown in the T = 0 panel and the no
DAB control (top right panels), Tfn-488 is expressed in endosomes throughout the cytoplasm as it recycles to the plasma membrane, as expected.
However, following DAB-dependent ablation, Tfn-488 is clustered in the recycling endosomes as evidenced by their perinuclear localization;
confirming recycling endosome ablation resulting in inhibition of TfnR trafficking back to the plasma membrane. Importantly, in both ablated and
non-ablated cells, BLAP-KCa3.1 traffics to the plasma membrane demonstrating that KCa3.1 does not traffic through TfnR-positive recycling
endosomes on the way to the plasma membrane. Images are representative of 3 separate experiments.
doi:10.1371/journal.pone.0092013.g009
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Figure 10. KCa3.1 does not traffic to the plasma membrane via RME-1-positive recycling endosomes. A. MDCK cells were transfected
with BLAP-KCa3.1 and either GFP-tagged WT (top panels) or DN (bottom panels) RME-1. Plasma membrane localized KCa3.1 could be labeled with
streptavidin-Alexa555 (T = 0) following biotinylation and this could be blocked by prior incubation with neutravidin (Block). Following block and ER/
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